Proposed mechanism of how renin-angiotensin system (RAS) blockers work, even when not lowering the tissue levels of angiotensin (Ang) II. Normally, Ang II generation occurs in a highly localized manner by angiotensin-converting enzyme (ACE), allowing local Ang II type 1 receptor (AT1R) stimulation. After treatment with an AT1R (ARB) or ACE inhibitor (ACEI), this is no longer possible, although upregulation of ACE and AT1R expression at alternative sites may occur, thus still allowing Ang II formation and AT1R stimulation but in a less efficient (‘diluted’) manner.